Mark Genovese
Corporate Officer/Principal at ELI LILLY AND COMPANY
Profile
Mark Genovese is currently the Senior Vice President-Immunology Development at Eli Lilly & Co. He previously worked as the Director at Kyverna Therapeutics, Inc. and as the Clinical Chief-Immunology & Rheumatology at Stanford University.
From 2020 to 2023, he served as the Senior Vice President-Inflammation Development at Gilead Sciences, Inc. Dr. Genovese completed his undergraduate degree at the University of Notre Dame and obtained his doctorate from The Johns Hopkins University School of Medicine.
Mark Genovese active positions
| Companies | Position | Start |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2023-10-15 |
Former positions of Mark Genovese
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2023-08-31 |
| KYVERNA THERAPEUTICS, INC. | Director/Board Member | - |
| Stanford University | Corporate Officer/Principal | - |
Training of Mark Genovese
| University of Notre Dame | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| KYVERNA THERAPEUTICS, INC. | Health Technology |
- Stock Market
- Insiders
- Mark Genovese
